Whether your trials are in danger of not being completed on time, their quality is questionable, halted by a regulatory agency Biomapas can rescue your study.
Naturally, these factors significantly affect your study timeline, regulatory filings, and eventual commercialization. After assessing the scope and type of study management deficiency and determining the type of remediation required, we can intervene as a third-party function.
Our experts can guide the project team and aid in managing and controlling the third-party CRO. Of course, we can also assume all responsibility for your study.
We offer dedicated project management staff with global experience and an understanding of local regulatory requirements. Our solutions focus on efficiency concerning site management and remote monitoring, and we continuously welcome technologies that optimize data flow, trial management, and reporting.